SUNDAY, June 2, 2019 (HealthDay News) — Cutting-edge prostate cancer drugs that help extend life in the toughest cases might also be useful in fighting less aggressive tumors, two new clinical trials suggest. Two drugs that interfere with cancer’s ability to use testosterone for fuel, apalutamide (Erleada) and enzalutamide (Xtandi),Continue Reading

THURSDAY, May 30, 2019 (HealthDay News) — Vaping is gaining a foothold in an unlikely population: New research shows a growing number of cancer patients are using electronic cigarettes. “The gradual but steady increase is quite striking,” said study author Dr. Nina Sanford, an assistant professor of radiation oncology atContinue Reading